Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue

NCT01937312 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

282

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Hypertension
Open Angle Glaucoma

Interventions

DRUG: Brinzolamide 1%/brimonidine 0.2% ophthalmic suspension
DRUG: Vehicle
DRUG: Prostaglandin analogue

Sponsor

Alcon Research